Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Clinical and Regulatory Operations Manager / Senior Manager

About the Company

T-Therapeutics is a next-generation T cell receptor (TCR) T cell engager (TCE) company developing novel therapeutics. The company harnesses T cell biology to create safe and effective treatments for cancer and autoimmune disease. The company is developing a pipeline of first-in-class drugs that are intended to become transformative medicines, reshaping the clinical landscape for patients with cancer or autoimmune diseases.

Research Assistant (Penfield Group)

About the Penfield Group

The Penfield Group works to understand the effects of seasonal changes in temperature on plant reproductive development. We work with the model species Arabidopsis and Arable crops to understand how weather and climate variation affect reproductive development, crop yield and quality. We have a particular focus on exploiting gene editing for sustainable agriculture in non-cereal crops.

The role

Events & Admin Lead

This role sits at the centre of the Cambridge-AZ-Beijing Life Sciences Collaboration Programme, a partnership between the University of Cambridge, AstraZeneca and partners in Beijing focused on international collaboration, knowledge exchange and innovation in life sciences.

You’ll lead the planning and delivery of the Cambridge-AZ-Beijing Life Sciences Forum, a flagship two-day conference held across Cambridge and Beijing. It will bring together people from academia, industry, healthcare and government, so the detail really matters.

Senior Legal Counsel

We’re Transforming Legal at Cancer Research UK  

Join us to get hands-on and take ownership of building a modern, strategic, and technology-enabled team that partners closely with the organisation, using data, AI, and innovative ways of working to deliver user-centric legal services that maximise our impact in beating cancer for everyone. We’re looking for builders, pathfinders, and changemakers who: 

Why IPO Markets Are Gaining Momentum Now

Global IPO markets are progressing on different trajectories. Prepared companies that maintain timing flexibility are positioned to win.

In brief

  • IPO markets are gaining momentum, with strong 1H activity setting the stage for what could be a historic 2H 2026.
  • Markets are strong, but execution windows may be episodic and could be shaped by mega-IPOs and geopolitics.
  • Companies pursuing public listings are using more flexible approaches — IPOs, direct listings and SPACs — to capitalize on improving market conditions.

Head of Programme Management

Qureight’s mission is to accelerate clinical trials and ensure breakthroughs in lung and heart disease reach patients without delay. Our AI-powered data and imaging curation platform enables the analysis of clinical imaging and other healthcare data, helping our customers bring treatments to market, faster.

NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer

Stevenage, UK, 3 August 2026 - NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company developing novel disease-modifying therapeutics that rectify mitochondrial dysfunction in neurodegenerative diseases, is pleased to announce the appointment of Claus Sundgreen M.D. as chief medical officer (CMO), effective 1 August 2026.

Subscribe to